40,900 Shares in Azenta, Inc. $AZTA Bought by Paradigm Capital Management Inc. NY

Paradigm Capital Management Inc. NY purchased a new position in Azenta, Inc. (NASDAQ:AZTA) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 40,900 shares of the company’s stock, valued at approximately $1,044,000.

Several other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in Azenta during the second quarter valued at approximately $192,152,000. Conestoga Capital Advisors LLC lifted its holdings in shares of Azenta by 116.1% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,844,546 shares of the company’s stock worth $60,105,000 after acquiring an additional 1,528,145 shares during the last quarter. Front Street Capital Management Inc. boosted its position in Azenta by 211.7% in the 1st quarter. Front Street Capital Management Inc. now owns 889,009 shares of the company’s stock valued at $18,785,000 after buying an additional 603,757 shares during the period. Millennium Management LLC lifted its stake in Azenta by 41.6% in the third quarter. Millennium Management LLC now owns 1,698,562 shares of the company’s stock worth $48,783,000 after acquiring an additional 499,216 shares during the period. Finally, Scopia Capital Management LP bought a new stake in Azenta during the third quarter valued at about $14,026,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on AZTA shares. Needham & Company LLC increased their price target on shares of Azenta from $33.00 to $37.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings lowered shares of Azenta from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $41.20.

Azenta Stock Down 12.1%

NASDAQ:AZTA opened at $32.88 on Tuesday. Azenta, Inc. has a 52-week low of $15.93 and a 52-week high of $41.73. The company has a market capitalization of $1.44 billion, a PE ratio of -11.91 and a beta of 1.37. The stock has a fifty day simple moving average of $28.12 and a 200-day simple moving average of $25.03.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. The firm had revenue of $161.18 million during the quarter, compared to analysts’ expectations of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.

Azenta Company Profile

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.